Peregrine Capital Management LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 4.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 129,988 shares of the medical equipment provider’s stock after selling 6,242 shares during the period. Intuitive Surgical makes up 2.0% of Peregrine Capital Management LLC’s holdings, making the stock its 6th biggest holding. Peregrine Capital Management LLC’s holdings in Intuitive Surgical were worth $67,849,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Creative Planning increased its stake in Intuitive Surgical by 9.3% in the third quarter. Creative Planning now owns 68,881 shares of the medical equipment provider’s stock valued at $33,839,000 after purchasing an additional 5,842 shares in the last quarter. Howard Capital Management Group LLC grew its holdings in shares of Intuitive Surgical by 4.5% during the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after buying an additional 92 shares during the last quarter. Capital Investment Advisors LLC boosted its stake in Intuitive Surgical by 7.3% during the 3rd quarter. Capital Investment Advisors LLC now owns 778 shares of the medical equipment provider’s stock valued at $382,000 after purchasing an additional 53 shares during the last quarter. Commonwealth Equity Services LLC lifted its holdings in shares of Intuitive Surgical by 3.6% in the third quarter. Commonwealth Equity Services LLC now owns 69,995 shares of the medical equipment provider’s stock valued at $34,386,000 after purchasing an additional 2,456 shares in the last quarter. Finally, Veracity Capital LLC boosted its position in shares of Intuitive Surgical by 6.4% during the third quarter. Veracity Capital LLC now owns 598 shares of the medical equipment provider’s stock valued at $294,000 after buying an additional 36 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Intuitive Surgical Price Performance
Shares of NASDAQ:ISRG opened at $595.55 on Tuesday. The company’s fifty day moving average price is $559.48 and its 200-day moving average price is $520.19. The firm has a market capitalization of $212.12 billion, a price-to-earnings ratio of 92.91, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.
Analyst Ratings Changes
Check Out Our Latest Stock Report on ISRG
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 408 shares of the stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the transaction, the executive vice president now directly owns 353 shares in the company, valued at approximately $208,181.75. This represents a 53.61 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock valued at $3,587,582 over the last 90 days. 0.90% of the stock is owned by insiders.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- What Investors Need to Know About Upcoming IPOs
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Conflicting Signals: Tempus AI’s Stock Market Rally
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.